According to estimates, hospitals mark up the prices of drugs for patients with private insurance by an average of 140% to 280%. (Photo: Rido/Shutterstock.com)
The cost of cancer care is a major concern for patients, payers and policymakers – and it continues to grow.
U.S. spending on all cancer therapies increased from $39.1 billion in 2015 to $67.5 billion in 2019. Some novel anticancer therapies are priced at more than $100,000 per year. As a result, some patients incur debt, reduce spending on other necessities or forgo recommended treatments altogether.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
